Final Subject Enrolled in Early Feasibility Study of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis
Antegrade iteration accepted into study – advancing this branched, all-in-one system
One-Year Results in Japanese Clinical Study Affirms the GORE® VIABAHN® Endoprosthesis as a Device-of-Choice for Treating Complex SFA Disease
New clinical study shows excellent patency consistent with previous study results of self-expanding stent-graft in long, complex SFA lesions
Gore Receives FDA Approval for New GORE® EXCLUDER® AAA Endoprosthesis Components
Expanded Treatment Options for Abdominal Aortic Aneurysms Provide More Patients with Access to Minimally Invasive Endovascular Repair
First Patient Enrolled in Gore EXCLUDER Iliac Branch Study
Multi-Center Study to Assess Safety and Effectiveness of GORE® EXCLUDER® Iliac Branch Endoprosthesis for Treatment of Common Iliac Artery Aneurysms (CIAA) or Aorto-Iliac Aneurysms (AIA)
GORE® EXCLUDER® Iliac Branch Endoprosthesis Is First Dedicated System of Its Kind Approved in Europe
First Successful Implants Completed in Italy and the United Kingdom, Providing Endovascular Repair to Iliac Arteries
First Patients Enrolled in Gore Thoracoabdominal Aortic Aneurysm Clinical Study
Device offers first and only complete “off-the-shelf” endovascular system specifically designed to treat aortic aneurysms involving visceral branch vessels
Gore Again Named One of the 100 Best Companies to Work For®
Every year since 1998: That’s how long W. L. Gore & Associates has appeared on the Fortune 100 Best Companies to Work For® list
Gore Launches Early Cannulation Capable GORE® ACUSEAL Vascular Graft
Results of early cannulation clinical trial presented at the 2013 VEITHsymposium
Study Confirms GORE® BIO-A® Tissue Reinforcement a Proven Alternative to Biologics in Hernia Repair
Two-year study demonstrates improved patient satisfaction with Gore material
Gore Announces First Commercial In-Human Use of GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System for TEVAR in Australia
New delivery system provides controlled and predictable placement of Gore’s highly conformable and time-tested stent graft